Study of first-line therapy comprising leucovorin calcium [calcium folinate], fluorouracil, and irinotecan (FOLFIRI) in patients with progressive locally advanced or metastatic duodenal-pancreatic endocrine tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fluorouracil; Folinic acid; Irinotecan
- Indications Neuroendocrine carcinoma
- Focus Therapeutic Use
- 30 May 2016 Biomarkers information updated
- 02 Feb 2007 New trial record.